These 2 stocks are worth watching amidst ongoing stock market rotation

The article highlights an ongoing rotation in the U.S. stock market, with capital moving out of technology and into healthcare and financials. It argues the S&P 500 is still range-bound, down more than 3% from its June high, but beneath the surface investors are repositioning into earnings-driven names. The two stocks singled out are Eli Lilly and Enova International. Eli Lilly is described as breaking out above a long-held $1,200 resistance, supported by bullish moving-average alignment, strong relative strength versus the S&P 500, and growth tied to GLP-1 momentum. Enova is presented as a high-growth financial stock consolidating near 52-week highs with strong volume and relative strength, supported by resilient credit conditions and attractive valuation. Overall sentiment is constructive on both names amid sector rotation.